Contact Us

TOURISM NEWS

Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial

Dec 10, 2024

Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company\'s ongoing Phase 1 trial in patients with Huntington\'s Disease

The 2024 Understanding China Conference (Guangzhou) Took Place

Dec 6, 2024

GUANGZHOU,China,Dec. 5,2024-- The 2024 Understanding China Conference (Guangzhou) took place on December 3 at the Guangzhou Yuexiu International Congress Center. Over 600 participants from the politic

SS&C to Present at Abu Dhabi Finance Week

Dec 6, 2024

WINDSOR,Conn.,Dec. 5,2024-- SS&C Technologies Holdings,Inc. (Nasdaq: SSNC),a global provider of software and software-enabled services for the financial services and healthcare industries,today a

The 136th Canton Fair: New Quality Productive Forces Driven by Technological Innovation Empowers China's Trade Upgrading

Dec 6, 2024

GUANGZHOU,China,Dec. 5,2024-- The 136th China Import and Export Fair in Guangzhou has been a beacon of achievement with an intended export turnover reaching USD 24.95 billion. Themed "Serving hig

Introducing io.Bridge: Zero-Install Interoperability for Seamless Workflows

Dec 6, 2024

LONDON and NEW YORK,Dec. 5,2024-- interop.io is proud to announce the launch of io.Bridge,a revolutionary solution to bring "interoperability everywhere." With io.Bridge,organizations can c

Daewoong Pharmaceutical Captivates Global Experts at AMWC-SEA with 'Nabolift,' Redefining Toxin Treatments

Dec 6, 2024

- At "AMWC SEA 2024," one of the world\'s top three aesthetic medicine congresses,the Nabota booth attracted over 500 visitors.

1 ... 60 61 62 63 64 65 66 ... 233